This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Raza A et al. (2001) Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. Blood 98: 958–965
Le Beau MM et al. (1986) Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 4: 325–345
Liu JJ et al. (2003) Erythroid gene suppression by NF-kappa B. J Biol Chem 278: 19534–19540
Corral LG et al. (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163: 380–386
Raza A et al. (2004) Remicade as TNF suppressor in patients with myelodysplastic syndromes. Leuk Lymphoma 45: 2099–2104
Acknowledgements
The synopsis was written by Alexandra King, Assistant Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A Raza is on the speakers' bureau, receives free drug/research grants and has been a consultant for Celgene Corp.
Glossary
- INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS)
-
A classification system to determine the severity of myelodysplastic syndromes, the chances of a patient's survival and the probability that disease progression to acute myeloid leukemia will occur
Rights and permissions
About this article
Cite this article
Raza, A., Galili, N. Lenalidomide for myelodysplastic syndromes: finally, hope not hype. Nat Rev Clin Oncol 2, 390–391 (2005). https://doi.org/10.1038/ncponc0244
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0244